Global Next-Generation Biologics Market to Grow at a CAGR of 14.42% During 2016-2020 - F. Hofmann-La Roche, Novo Nordisk, Sanofi
According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings. Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine...
View full press release